Indication
Morton's Neuroma
1 clinical trial
1 product
Clinical trial
Phase I Open Label Clinical Trial Using Resiniferatoxin, A Non-Opioid Medication, For the Management of Refractory Morton's Neuroma PainStatus: Recruiting, Estimated PCD: 2025-12-01
Product
Resiniferatoxin